Stone or stricture as a cause of extrahepatic cholestasis -: do liver function tests predict the diagnosis?

被引:14
作者
Karvonen, Jukka
Kairisto, Veli
Gronroos, Juha M.
机构
[1] Univ Turku, Dept Surg, Turku, Finland
[2] Univ Turku, Dept Clin Chem, Turku, Finland
[3] Univ Turku, Dept Emergency, Turku, Finland
关键词
bile duct stone; bile duct stricture; bilirubin; cholestasis; jaundice; liver function test;
D O I
10.1515/CCLM.2006.261
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Cholestasis, roughly divided into intrahepatic and extrahepatic forms, is a clinical challenge. Extrahepatic cholestasis, characterized by dilated bile ducts, is caused by either a bile duct stone or stricture, with stricture most often related to a malignancy. The aim of the present study was to analyze the value of common liver function tests in separating patients with malignant bile duct strictures from those with stones. Methods: All consecutive patients admitted for endoscopic retrograde cholangiopancreatography (ERCP) were included in the study population if a bile duct stricture related to a malignancy was found by ERCP (n = 103) or if a bile duct stone was successfully extracted during ERCP, thus confirming the diagnosis of a stone (n=109). Plasma alkaline phosphatase, gamma-glutamyltransferase, alanine aminotransferase and bilirubin values were determined in the morning before ERCP. Results: Plasma bilirubin (p < 0.001), alkaline phosphatase (p < 0.001) and alanine aminotransferase (p=0.040) levels were significantly higher in patients with malignant bile duct strictures than in those with bile duct stones. In addition, gamma-glutamyltransferase levels seemed to be higher in patients with malignant strictures than in those with stones, although the difference did not reach statistical significance (p=0.053). In receiver operating characteristic analyses, bilirubin proved to be the best laboratory test in differentiating patients (p=0.001 vs. alkaline phosphatase, p < 0.001 vs. alanine aminotransferase and p < 0.001 vs. gamma-glutamyltransferase). With a plasma bilirubin cutoff value of 145 mu mol/L, four out of five patients were categorized correctly. Conclusions: Plasma bilirubin seems to be the best liver function test in distinguishing patients with malignant bile duct strictures from those with bile duct stones. This routine test should receive more attention in clinical decision-making than has previously been given.
引用
收藏
页码:1453 / 1456
页数:4
相关论文
共 13 条
[1]   Choledocholithiasis and bile duct stenosis: Diagnostic accuracy of MR cholangiopancreatography [J].
Becker, CD ;
Grossholz, M ;
Becker, M ;
Mentha, G ;
dePeyer, R ;
Terrier, F .
RADIOLOGY, 1997, 205 (02) :523-530
[2]  
Chang L, 1998, AM J GASTROENTEROL, V93, P527
[3]   AGA technical review on the evaluation of liver chemistry tests [J].
Green, RM ;
Flamm, S .
GASTROENTEROLOGY, 2002, 123 (04) :1367-1384
[4]   A METHOD OF COMPARING THE AREAS UNDER RECEIVER OPERATING CHARACTERISTIC CURVES DERIVED FROM THE SAME CASES [J].
HANLEY, JA ;
MCNEIL, BJ .
RADIOLOGY, 1983, 148 (03) :839-843
[5]   HEALTH-BASED REFERENCE VALUES OF THE MINI-FINLAND HEALTH SURVEY .1. SERUM GAMMA-GLUTAMYLTRANSFERASE, ASPARTATE-AMINOTRANSFERASE AND ALKALINE-PHOSPHATASE [J].
JARVISALO, J ;
MAATELA, J ;
MAKI, J ;
MARNIEMI, J ;
REUNANEN, A .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1989, 49 (07) :623-632
[6]   SOFTWARE FOR ILLUSTRATIVE PRESENTATION OF BASIC CLINICAL CHARACTERISTICS OF LABORATORY TESTS - GRAPHROC FOR WINDOWS [J].
KAIRISTO, V ;
POOLA, A .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 :43-60
[7]  
KLAUKE R, 1993, EUR J CLIN CHEM CLIN, V31, P901
[8]   Utility of magnetic resonance cholangiography in the evaluation of biliary obstruction [J].
Magnuson, TH ;
Bender, JS ;
Duncan, MD ;
Ahrendt, SA ;
Harmon, JW ;
Regan, F .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1999, 189 (01) :63-71
[9]  
Onken JE, 1996, AM J GASTROENTEROL, V91, P762
[10]   VALUE OF SERUM ALKALINE-PHOSPHATASE, AMINOTRANSFERASES, GAMMA-GLUTAMYL TRANSFERASE, LEUCINE AMINOPEPTIDASE, AND BILIRUBIN IN THE DISTINCTION BETWEEN BENIGN AND MALIGNANT DISEASES CAUSING JAUNDICE AND CHOLESTASIS - RESULTS FROM A PROSPECTIVE-STUDY [J].
PASANEN, P ;
PIKKARAINEN, P ;
ALHAVA, E ;
PARTANEN, K ;
PENTTILA, I .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1993, 53 (01) :35-39